Mark Offer
Impact in
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 15
-
- Multiple Myeloma Research and Treatments 4
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Philip N. Hawkins (15 shared papers)Helen J. Lachmann (15 shared papers)Julian D. Gillmore (12 shared papers)Ashutosh Wechalekar (11 shared papers)Hugh J. B. Goodman (6 shared papers)Mark B. Pepys (2 shared papers)Jayshree Joshi (1 shared paper)Glenys A. Tennent (1 shared paper)
- Journals
- Blood (8 papers)Haematologica (2 papers)British Journal of Haematology (1 paper)Leukemia & lymphoma (1 paper)British Journal of Hospital Medicine (1 paper)
- Partner nations
- United KingdomUnited StatesNew Zealand
In The Last Decade
Mark Offer
17 papers receiving 525 citations
Peers
Comparison fields: 5 of 35
- Genetics 148
- Hematology 119
- Nephrology 62
- Molecular Biology 499
- Rheumatology 68
Countries citing papers authored by Mark Offer
This map shows the geographic impact of Mark Offer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Offer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Offer more than expected).
Fields of papers citing papers by Mark Offer
This network shows the impact of papers produced by Mark Offer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Offer. The network helps show where Mark Offer may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Offer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 177 | |
| 2 | 2010 | 105 | |
| 3 | 2008 | 94 | |
| 4 | 2005 | 94 | |
| 5 | 2008 | 18 | |
| 6 | 2015 | 11 | |
| 7 | 2006 | 10 | |
| 8 | 2009 | 8 | |
| 9 | 2005 | 7 | |
| 10 | 2020 | 5 | |
| 11 | Treatment of cryopyrin associated periodic fever syndrome with a fully human anti-IL-1beta monoclonal antibody (ACZ885): results from a subcutaneous administration study | 2008 | 4 |
| 12 | CTD versus Mel-Dex as upfront treatment in AL amyloidosis: a matched case-control study | 2010 | 3 |
| 13 | 2005 | 2 | |
| 14 | 2005 | 2 | |
| 15 | 2015 | 2 | |
| 16 | 2008 | 2 | |
| 17 | Natural history and outcome of amyloidosis in the elderly | 2006 | 1 |
About Mark Offer
Mark Offer is a scholar working on Molecular Biology, Hematology, Nephrology, Genetics and Oncology, having authored 17 papers that have together received 545 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Multiple Myeloma Research and Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Parathyroid Disorders and Treatments (2 papers), Hermeneutics and Narrative Identity (1 paper), Alzheimer's disease research and treatments (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Genetics (148 citations), Hematology (119 citations), Nephrology (62 citations), Molecular Biology (499 citations) and Rheumatology (68 citations). Mark Offer has collaborated with scholars based in United Kingdom, United States and New Zealand. Frequent co-authors include Philip N. Hawkins, Helen J. Lachmann, Julian D. Gillmore, Ashutosh Wechalekar, Hugh J. B. Goodman, Mark B. Pepys, Jayshree Joshi, Glenys A. Tennent, Winston L. Hutchinson and David J. Millar. Their work appears in journals such as Blood, Haematologica, British Journal of Haematology, Leukemia & lymphoma and British Journal of Hospital Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.